[Home]   [Full version]  

New finding in rare eye disease

Jul 14 ,Medicine & Health



Full size image
(PhysOrg.com) -- Researchers have made a finding which could pave the way for new treatments for sufferers of a rare eye disease which can lead to blindness.

In a paper published in the Journal of Pathology, scientists reveal they have discovered why mutations in a key gene can cause the cornea to go opaque and lead to sight loss.

Pax6 is the gene responsible for the development of the eye and mutations of it can cause the cornea to go cloudy.

Corneas - our windows on the world – are delicate, transparent tissues which are constantly exposed to potentially damaging environmental factors such as daylight, ultraviolet light and high levels of oxygen.

Normal corneas contain proteins that protect against the day to day stress of coping with these environmental stresses.

But around one in 40,000 people have Pax6 mutations which lead to them developing a condition called Aniridia, where the iris of the eye is missing.

As well as having no iris, most sufferers will develop some degree of corneal cloudyness which is called Aniridia-Related Keratopathy or ARK.

Now researchers have found that people with ARK have tiny holes in their corneas, which open up the corneas to extra levels of stress. They also discovered that they have less of the protective proteins, which results in their eyes being unable to cope with everyday conditions. Over time, this leads to the corneas going cloudy.

Dr Martin Collinson, a Senior Lecturer in Biomedical Sciences at the University of Aberdeen, led the research team. He said: "In the worst cases Aniridia-Related Keratopathy can be chronically painful and sight threatening. Current therapy is surgery, anti-inflammatory drugs, or nothing at all."

The researchers found that if they applied chemicals to diseased corneas, they were able to reduce the stress caused by oxygen. This in turn gave cells on the eye's surface more of a fighting chance of protecting the eye.

Dr Collinson added: "Our findings provide answers to a disease that has been very poorly understood and is rather difficult to treat.

"We hope that our studies could potentially lead to new treatments for people with ARK that could involve eye drops as opposed to surgery."

Source: University of Aberdeen

Related stories:

Eye research breakthrough yields new clues for treating diseases
An international research team has made a discovery about an eye function that could pave the way for better therapies for a wide range of diseases including cancer.
New-generation artificial cornea could restore vision for millions worldwide
An improved artificial cornea, which could restore the vision of more than 10 million people worldwide who are blind due to diseased corneas, finally is moving toward reality, scientists in California conclude in a new analysis of research on the topic. Their study is scheduled for the June 6 issue of ACS' Biotechnology Progress.
ISU researcher performs first veterinary corneal implant procedure in US
Sinisa Grozdanic an assistant professor of Veterinary Clinical Sciences performed the surgery that restored sight to 7-year-old Dixie, a Mountain Cur breed owned by Brett Williams of Runnells.
Dallas area cornea shortages could benefit from national study
Surgeons and patients from UT Southwestern Medical Center and UT Southwestern Transplant Services Center joined in a landmark study showing that corneas from older donors are as successful for transplants after five years as is tissue from younger donors, allowing possible expansion of the donor pool.
Moth eyes may hold key to more efficient solar cells
One of the difficulties with solar power is that solar cells are notoriously inefficient. Some of that inefficiency, says Peng Jiang, is due to the fact that silicon is reflective. Jiang, an assistant professor at the University of Florida, tells PhysOrg.com that there are “disadvantages to the anti-reflective coating currently used in solar cells.”
Bone marrow stem cells may cure eye disease
Adult bone marrow stem cells may help cure certain genetic eye diseases, according to University of Cincinnati (UC) researchers.
An artificial cornea is in sight, thanks to biomimetic hydrogels
If eyes are "the windows of the soul," corneas are the panes in those windows. They shield the eye from dust and germs. They also act as the eye's outermost lens, contributing up to 75 percent of the eye's focusing power. On Sept. 11 in San Francisco at the annual meeting of the American Chemical Society, chemical engineer Curtis W. Frank will present a novel biomimetic material that's finding its way into artificial corneas. It's a hydrogel, or polymer that holds a lot of water. That material may promise a new view for at least 10 million people worldwide who are blind due to damaged or diseased corneas or many millions more who are nearsighted or farsighted due to misshapen corneas.
Scientists discover why cornea is transparent, allowing vision
Scientists at the Harvard Department of Ophthalmology's Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary (MEEI) are the first to learn why the cornea, the clear window of the eye, is free of blood vessels--a unique phenomenon that makes vision possible.

News discussion:

Medicine & Health news

[Home]   [Full version]